Last week, I wrote about biotech's red light, green light recovery.🚦 "This is a very different biotech market than we’ve seen before." Every time somebody (us, too!) writes about a market comeback, it feels like stocks drop the very next day. In #biotech, it appears like the factors the industry can control (R&D, data, financings) are heading in the right direction. And they're running into factors the industry can't control (interest rates, AI sucking the air out of the room for generalists, US-China). You can read the whole thing here, with a quote from Tim Opler + his great newsletter that lent several helpful stats: https://lnkd.in/eYm58Q7t

From Axios and Alison Snyder - Here is the most concise primer I've read on how US-China competition is playing out in biotech and biosecurity. https://lnkd.in/eahvPbYY

Without the right Bio-IT strategy, #LifeScience firms may struggle to power the engine for future scientific #innovation, discovery, and development. In this guide, we'll share the strategic considerations and best practices your #biotech or #pharma can implement to ensure you're well-positioned to advance the field of medicine and work toward the promise of curing the incurable. Read it here: https://loom.ly/a-uBywA

📢 Introducing GENE-UP® TYPER — Now You Know! Identify the root cause of contamination and receive actionable data to make impactful decisions in under 24 hours. ⏱ ➡️ Now you know what it is, what to do, and where it comes from. Visit our website to learn more about our latest game-changing innovation: https://lnkd.in/eu48ximE

Quick snippet share from my chat with Tristan the other week, in which we discussed everything #GenAI from marketing to biotech breakthroughs. More to come.

🕦 Fed up to wait for weeks to identify a pathogen, especially during root cause analyses? 👨🔬 We incorporated state of the art data science into a freeze-dried PCR pellet and an intuitive platform to provide an easy-to-use and fast typing solution - a typing result as soon as the day after you detected a pathogen! 💪So proud of such interdisciplinary work with amazing scientists from many different fields, and happy to have contributed to it too! #biomerieux #gamechanger #foodsafety #RCA #pathogen

A PCR evolution ? No a PCR Revolution. Now you can Type a Salmonella or Listeria monocytogenes, Now you can identify pathogens clusters, Now you can conduct a Pathogen root cause with a simple PCR equipment in 1h…. Now you know ! Now bioMerieux

#VCs continue to pour money into innovative platforms in 2023 and beyond, that could revolutionize the #biotech sector. Innovative platform technologies such as #drugdiscovery enabled by machine learning (ML), #celltherapies, #genetherapies and #geneediting technology have dominated #biotechfunding over the past few years because they tend to address a broad array of indications. Not surprisingly, two-thirds of the investment from 2019-2021 went to #biotech companies with next-generation biotech platform technologies that constitute a base or infrastructure on which other therapies can be developed, and could #transform the industry. Check out the full McKinsey & Company article in the comments for additional details.

Some Trends of 2030s from Yury Melnichek. I am sincerely interested in how biotech will develop. I will keep an eye on this area, it can change our lives very dramatically. #BelTechGlobal

Going to BioProcess Europe next week? If so, be sure to catch up with the Invert team. Join Alex Felt and Jared Cochran in 🇦🇹Vienna🇦🇹 from April 9th to 12th as they explore the future of #biomanufacturing at Europe’s leading #bioprocessing event. In addition to learning from foremost experts and innovators, Alex and Jared will speak with bioprocessing professionals about our favorite topics: #DataManagement, #MachineLearning, and bioprocess #modeling. With the rise of next-generation drug modalities and demand for more efficient biomanufacturing efforts, there’s a lot of need to better analyze bioprocess data and use it for predictive ML-based models. The future of biomanufacturing needs software support to help transform all that data into actionable knowledge and clear insights. That’s where Invert comes in. Want to hear how Invert can support your bioprocessing efforts in person? Use the link in the comments to schedule a chat with Invert. See you in Vienna! 🚀